Sana Biotechnology, Inc. (SANA) NASDAQ
3.20
+0.15(+4.92%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.20
+0.15(+4.92%)
Currency In USD
| Previous Close | 3.05 |
| Open | 2.89 |
| Day High | 3.22 |
| Day Low | 2.87 |
| 52-Week High | 6.55 |
| 52-Week Low | 1.26 |
| Volume | 3.27M |
| Average Volume | 2.61M |
| Market Cap | 853.97M |
| PE | -3.33 |
| EPS | -0.96 |
| Moving Average 50 Days | 3.75 |
| Moving Average 200 Days | 3.95 |
| Change | 0.15 |
Sana Biotechnology to Present at March 2026 Investor Conferences
GlobeNewswire Inc.
Feb 23, 2026 9:05 PM GMT
SEATTLE, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences
Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer
GlobeNewswire Inc.
Feb 17, 2026 2:00 PM GMT
SEATTLE, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the appointment of Brian Piper as Executive Vice President, Chief
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 07, 2026 9:26 PM GMT
SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 44th Annual J.P. Morg